Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
- Marc, Rondy
- Esther, Kissling
- Hanne-Dorthe, Emborg
- Alin, Gherasim
- Richard, Pebody
- Ramona, Trebbien
- Francisco, Pozo
- Amparo, Larrauri
- Jim, Mcmenamin
- Marta, Valenciano
- D'Agaro, Pierlanfranco
Publication date
January 2018
DOI Publisher
European Centre for Disease Control and Prevention (ECDC) ISSN
1560-7917Abstract
Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates
Add to ORKG